Jaume Pons
President & CEO at ALX Oncology Holdings Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: ALX Oncology Holdings Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ALX Oncology Holdings Inc. June 16, 202399.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 19, 2025 | ALX Oncology Holdings Inc. | Open-market sale | −1,326 | $1.15 | $1,525 |
| Dec 30, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −10,796 | $1.58 | $17,058 |
| Aug 14, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −1,937 | $2.58 | $4,997 |
| Jul 11, 2024 | ALX Oncology Holdings Inc. | Option exercise | +20,000 | $0.99 | $19,800 |
| Jul 11, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −20,000 | $7.90 | $158,000 |
| Jul 1, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −10,758 | $5.82 | $62,612 |
| Jun 4, 2024 | ALX Oncology Holdings Inc. | Option exercise | +20,000 | $0.99 | $19,800 |
| Jun 4, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −20,000 | $8.43 | $168,600 |
| May 6, 2024 | ALX Oncology Holdings Inc. | Option exercise | +20,000 | $0.99 | $19,800 |
| May 6, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −20,000 | $15.92 | $318,400 |
| Apr 16, 2024 | ALX Oncology Holdings Inc. | Option exercise | +25,846 | $0.99 | $25,588 |
| Apr 16, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −50,000 | $14.20 | $710,000 |
| Apr 4, 2024 | ALX Oncology Holdings Inc. | Open-market sale | −20,000 | $11.15 | $223,000 |
| Feb 14, 2024 | ALX Oncology Holdings Inc. | Grant or award | +30,000 | — | — |
| Dec 29, 2023 | ALX Oncology Holdings Inc. | Open-market sale | −7,179 | $15.04 | $107,972 |
Questions about Jaume Pons
What boards is Jaume Pons on?
Jaume Pons sits on the board of ALX Oncology Holdings Inc.
What company is Jaume Pons the CEO of?
Jaume Pons is President & CEO of ALX Oncology Holdings Inc.
How long has Jaume Pons served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.